We were also unable to use gold standard measurements to confirm dementia diagnosis.42 The study was conducted during a period when newer classes of diabetes medications (eg, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists) were not frequently prescribed. Here, SLC5A2 is linked to dementia.